Prospective evaluation of lipid management following acute coronary syndrome in non-Western countries.
Ann Marie NavarSimon T MatskeplishviliMiguel Urina-TrianaMohammed ArafahJaw-Wen ChenApichard SukonthasarnValérie Corp Dit GentiVéronique DaclinEric D PetersonPublished in: Clinical cardiology (2021)
Our real-world registry found that a third or more of post-ACS patients did not have a repeat LDL-C follow-up measurement. In those with an LDL-C follow-up measurement, more than half (52.9%) were not achieving a <70 mg/dl LDL-C goal, despite a greater uptake of high-intensity statin therapy than has been observed in recent evidence. This demonstrates the opportunity to improve post-ACS lipid management in global community practice.
Keyphrases
- acute coronary syndrome
- high intensity
- end stage renal disease
- low density lipoprotein
- healthcare
- percutaneous coronary intervention
- antiplatelet therapy
- newly diagnosed
- chronic kidney disease
- ejection fraction
- primary care
- fatty acid
- mental health
- cardiovascular disease
- coronary artery disease
- prognostic factors
- south africa
- stem cells
- type diabetes
- patient reported outcomes
- cell therapy
- replacement therapy
- body composition